STEK - Stemtech Corp
0.0002
0 0%
Share volume: 13,072,337
Last Updated: 03-27-2026
Wholesale/Wholesale – Drugs & Drug Proprietaries:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
0.00%
View ratios
| Fiscal Date | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|
| Fiscal Quarter | Q2 2025 | Q3 2025 | |
| Report Date | 08-19-2025 | 11-19-2025 | |
| Total revenue | 697.925 K | 852.300 K | |
| Cost of revenue | 145.909 K | 169.817 K | |
| Gross profit | 552.016 K | 682.483 K | |
| 23.63% | |||
| Operating expenses | 819.197 K | 1.008 M | |
| Selling general and admin | 819.197 K | 1.008 M | |
| Research and development | 0.000 | 0.000 | |
| Total expenses | 853.004 K | 1.022 M | |
| 19.78% | |||
| Operating income | -300.988 K | -339.217 K | |
| Ebit | -216.553 K | -303.842 K | |
| Pretax income | -296.280 K | -812.541 K | |
| 174.25% | |||
| Income tax | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | |
| Net income | -296.280 K | -812.541 K | |
| -174.25% |